Vertex Pharmaceuticals | VRTX - Market Capitalization

Stock Price
487.43
Daily Change
6.42 1.33%
Monthly
2.22%
Yearly
1.47%
Q1 Forecast
462.12

Vertex Pharmaceuticals reported $125.77B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Agios Pharmaceuticals USD 1.6B 16M Feb/2026
Alnylam Pharmaceuticals USD 39.74B 12.8B Feb/2026
Amgen USD 201.45B 25.2B Feb/2026
Arrowhead Research USD 8.04B 973M Feb/2026
Biogen USD 27.01B 1.19B Feb/2026
BioMarin Pharmaceutical USD 11.99B 575M Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Gilead Sciences USD 183.59B 31.31B Feb/2026
Incyte USD 22.7B 3.31B Feb/2026
Insmed USD 23.91B 13.21B Feb/2026
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
J&J USD 500.24B 67.44B Dec/2025
Merck USD 300.37B 39.11B Feb/2026
Moderna USD 16.5B 6.41B Feb/2026
Neurocrine Biosciences USD 13.68B 465M Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Pfizer USD 152.89B 11.32B Feb/2026
PTC Therapeutics USD 5.36B 744M Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Ultragenyx Pharmaceutical USD 1.94B 284M Feb/2026
United Therapeutics USD 18.96B 6B Sep/2025
Vertex Pharmaceuticals USD 120.12B 5.09B Feb/2026